Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akero, Beigene, Canbridge, Cstone, Esteve, Stealth, Vectivbio.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: AB Science, Aim, Alphageneron, Ambulero, Biogen, Biontech, Chipscreen, First Wave, Genmab, Janssen, Innocare, Moleculin, Pfizer, Plus, Sage.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Adocia, Advaccine, Asieris, Beigene, Brii, Curevac, Escugen, H. Lundbeck, Hoth, Inovio, Kintor, Merck, Nrx, Otsuka, Regeneron, Ridgeback, Roche, Sorrento, Tonghua Dongbao.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: SPR Therapeutics, Venus Concept.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adamis, Avadel, Avidity, Boehringer, Enochian, Gilead, I-Mab, Leo, Omeros, Oyster Point, Regeneron, Revance, Roche, Saniona, Sanofi, Som, United, UCB, Xilio.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Histosonics, Thermo Fisher Scientific.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Apellis, BMS, Chiesi, Gilead, Janssen, Lava, Merck, Pfizer, Rhythm, Sobi.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Agilent, Electrocore, Feops, Varian.